Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier LabfiledCriticalServier Lab
Priority to TNP2006000224ApriorityCriticalpatent/TNSN06224A1/en
Publication of TNSN06224A1publicationCriticalpatent/TNSN06224A1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Nouvelle forme cristalline V de l'agomelatine, son procedé de préparation et les compositions pharmaceutiques qui la contiennent. Forme cristalline V du composé de formule (I) : caractérisée par son diagramme de diffraction X sur poudre. MédicamentsNovel crystalline form V agomelatine, its method of preparation and pharmaceutical compositions containing it. V crystalline form of the compound of formula (I): characterized by its powder X-ray diffraction pattern. pharmaceuticals
TNP2006000224A2006-07-202006-07-20
Novel crystalline form V agomelatine, its method of preparation and pharmaceutical compositions containing it.
TNSN06224A1
(en)
NOVEL CRYSTALLINE FORM "ALPHA" OF TERT-BUTYLAMINE SALT OF PERINDOPRILL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME